Skip to main content

ERRATUM article

Front. Immunol., 27 July 2023
Sec. Vaccines and Molecular Therapeutics

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins

  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
The HLA class-II immunopeptidomes of AAV capsids proteins

by Brito-Sierra CA, Lannan MB, Siegel RW and Malherbe LP (2022). Front. Immunol. 13:1067399. doi: 10.3389/fimmu.2022.1067399

Due to a production error, an author name was incorrectly spelled as “Robert J. Siegel”. The correct spelling is “Robert W. Siegel”. The publisher apologizes for this mistake.

The original version of this article has been updated.

Keywords: AAV (Adeno-associated virus), immunogenicity, immunopeptidome, gene therapy, risk assessment, CD4+, HLA

Citation: Frontiers Production Office (2023) Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins. Front. Immunol. 14:1261322. doi: 10.3389/fimmu.2023.1261322

Received: 19 July 2023; Accepted: 19 July 2023;
Published: 27 July 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.